Two continents. One simple choice.

Although an ocean may divide them, when it comes to choosing the right pharma services company, distance knows no bounds.

As market leaders in an abecedarian of pharmaceutical services, European-based QUINTA-ANALYTICA are proud to have been chosen to provide a plethora of their offerings by US transdermal patch technology specialists, Greene Street Pharmaceuticals, despite being located a ‘mere’ 7000km away.

Being selected over more local service providers, Quinta-Analytica has been contracted as the exclusive API sourcing partner and CRO for BE studies, bioanalytical analyses, and preclinical studies for Greene Street as it strengthens its foothold in bringing transdermal solutions to the mainstream.

By selecting Quinta-Analytica with its world-class network of services, over 20 years of experience and fully certified coverage of the whole pharmaceutical spectrum, it will enable Greene Street to realize its model of offering a combination of discovery, development, and direct manufacture of transdermals both at home and abroad.

Are looking for a world-class pharmaceuticalindustry service provider? Don’t let geography influence you, get in touch with us today!

Additional News

  • 22 června 2023

    Quinta Analytica Partners with EvidentIQ to Enhance Efficiency of Phase 1 Studies

    EvidentIQ partners with Quinta-Analytica to enhance Phase 1 study efficiency

  • 15 června 2023

    Novavax & Conscio: Behind the Scenes of Vaccine Development

    Discover how the Conscio Group and renowned vaccine manufacturer Novavax collaborate behind the scenes to ensure quality and efficiency in vaccine production.

  • 8 června 2023

    Clinical Tips – Drug Interactions in Advanced Clinical Trial Design

    Drug interactions play a key role in the design of clinical trials. Learn how we investigate such interactions when conducting pharmacokinetic/bioequivalence studies and while offering end-to-end support throughout the process.